Valuation: Beijing Airdoc Technology Co., Ltd.

Market Cap 882M 1.02B 130M 114M 105M 97.16M 183M 12.5B 186M 1.25B 492M 6.12B 489M 478M 21.08B P/E 2026 *
-23.4x
P/E 2027 * -432x
Enterprise Value 882M 1.02B 130M 114M 105M 97.16M 183M 12.5B 186M 1.25B 492M 6.12B 489M 478M 21.08B EV / Sales 2026 *
3.5x
EV / Sales 2027 * -
Free-Float
18.85%
Yield 2026 *
-
Yield 2027 * -
1 day+2.04%
1 week-4.76%
Current month-9.75%
1 month-16.53%
3 months-15.25%
6 months-23.08%
Current year-12.51%
1 week 9.15
Extreme 9.15
10.8
1 month 9.15
Extreme 9.15
11.99
Current year 9.15
Extreme 9.15
13.77
1 year 9.15
Extreme 9.15
16
3 years 7.88
Extreme 7.88
18.38
5 years 7.88
Extreme 7.88
74.95
10 years 7.88
Extreme 7.88
74.95
Manager TitleAgeSince
Chief Executive Officer 43 2015-09-08
General Counsel - 2021-02-28
Corporate Secretary - 2022-01-18
Director TitleAgeSince
Director/Board Member 45 2024-09-19
Chairman 43 2015-09-08
Director/Board Member 51 2022-05-18
Date Insider Type Main position Quantity % Market Cap.
05-28Other

Chief Executive Officer

-165,400 0.1597%
01-19Other

Chief Executive Officer

418,500 0.4041%
25-09-23Other

Chief Executive Officer

35,000 0.0338%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%-4.76%-20.63%-8.76% 128M
+2.37%+5.81%-28.72%-3.76% 31.37B
-1.14%-9.20%-40.68%+192.20% 14.22B
-0.42%+0.64%-21.97%+71.65% 5.7B
+7.41%+2.77% - - 2.2B
+2.09%+4.01%+72.28%-34.23% 2.09B
-0.21%-10.43% - - 1.82B
+0.58%-1.41%-34.81% - 1.07B
-1.63%-13.31%+44.57%+101.11% 911M
-1.59%-2.37%-38.48%+233.93% 805M
Average +0.95%-5.11%-8.56%+78.88% 6.03B
Weighted average by Cap. +1.23%-2.48%-26.36%+58.53%

Financials

2026 *2027 *
Net sales 252M 292M 37.21M 32.52M 30.06M 27.77M 52.3M 3.57B 53.24M 358M 141M 1.75B 140M 137M 6.03B -
Net income -39M -45.13M -5.76M -5.03M -4.65M -4.3M -8.09M -553M -8.24M -55.48M -21.77M -271M -21.63M -21.15M -933M -
Net Debt - -
Logo Beijing Airdoc Technology Co., Ltd.
Beijing Airdoc Technology Co Ltd is a China-based company primarily engaged in providing artificial intelligence (AI)-empowered retina-based early detection, diagnosis and health risk assessment solutions. The Company’s main products include Myopia Prevention and Control AI (PBM-AI), Retinal Detection AI (Retina AI) and Stress Resilience Monitoring AI (Neuro-AI). The Company offers health risk assessment solutions with the ability to detect risk indicators, including risk assessments of retinal abnormalities, retinal vascular diseases, vitreous abnormalities, retinal tumors, optic nerve pathologies, macular diseases, congenital anomalies of the retina, cardiovascular disease and anemia. The Company conducts its business in the domestic and overseas markets.
Employees
181
Date Price Change Volume
26-07-15 HK$10.00 +2.04% 79,100
26-07-14 HK$9.800 +0.51% 28,800
26-07-13 HK$9.750 -7.50% 72,700
26-07-10 HK$10.54 -1.03% 53,400
26-07-09 HK$10.65 +1.43% 51,900
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.641CNY
Average target price
11.22CNY
Spread / Average Target
+29.83%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2251 Stock